Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
Acute Leukemia News
EHA 2019Measurable Residual Disease in AML Ups Post-HSCT Relapse RiskMeasurable residual disease, detected with next-generation genomic sequencing, is associated with a significantly increased risk for relapse. Experts question the prognostic ability of other assessment tools.
